Table 2. The relationship between favorable response and LGL lymphocytosis .
| Reference | MMR | CMR | ||||
|---|---|---|---|---|---|---|
| LGL+ | LGL− | P | LGL+ | LGL− | P | |
| Mustjoki et al.15 | 17/22 (77%) | 2/8 (25%) | 0.015 | 12/22 (55%) | 1/8 (13%) | 0.047 |
| Nagata et al.17 | 8/9 (89%) | 6/11 (55%) | 0.08 | NR | ||
| Kim et al.18 | 8/8 (100%) | 3/10 (30%) | 0.01 | 7/8 | 2/10 | 0.003 |
| Tanaka et al.19 | NR | 4/5 (80%) | 0/3 (0%) | 0.01 | ||
| Lee et al.21 | 12/23 (52%) | 5/27 (15%) | 0.05 | 10/23 (44%) | 4/27 (15%) | 0.024 |
| Mustjoki et al.29 | 7/7 (100%) | 1/30 (3%) | <0.00 | 6/7 (86%) | 1/30 (3%) | <0.00 |
MMR, major molecular response; CMR, complete molecular response; NR, not reported.